Postacute Stromal Cell–Derived Factor-1α Expression Promotes Neurovascular Recovery in Ischemic Mice
- 1 June 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 45 (6) , 1822-1829
Abstract
Background and Purpose—: Acute interventions of stroke are often challenged by a narrow treatment window. In this study, we explore treatments in the postacute phase of stroke with wider windows of opportunity. We investigated the effects of stromal cell–derived factor (SDF-1α) in neurovascular recovery during the postacute phase and downstream signaling pathways, underlying SDF-1α–mediated neurovascular recovery. Methods—: Adult male Institute of Cancer Research (ICR) mice underwent middle cerebral artery occlusion. One week after middle cerebral artery occlusion, the animals received stereotactic injection of adenoassociated virus (AAV) carrying SDF-1α gene as treatment or AAV-green fluorescent protein as control and were monitored for 5 weeks. Neurobehavioral outcomes were evaluated, and brain atrophy was measured. Neurogenesis and angiogenesis were examined. The proliferation and migration of neural progenitor cells were evaluated. Downstream pathways of SDF-1α were investigated. Inflammatory response was monitored. Results—: Neurobehavioral outcomes were improved, and brain atrophy was greatly reduced for ≤5 weeks in AAV-SDF-1α groups when compared with the control. SDF-1 receptor CXCR4 was upregulated and colocalized with neural and endothelial progenitor cells. The number of nestin + and doublecortin + /bromodeoxyuridine + cells in the subventricular zone, doublecortin + and neuron + /bromodeoxyuridine + cells in the perifocal region, and cluster of differentiation (CD)31 + and bromodeoxyuridine + /CD31 + microvessels are also significantly increased in AAV-SDF-1α groups. Administration of CXCR4 antagonist AMD3100 eliminated the beneficial effects of SDF-1α. SDF-1α/CXCR4 interaction activated AKT, extracellular signal-regulated kinases (ERK), and P38 mitogen-activated protein kinase (MAPK) signaling pathways but not the c-Jun N-terminal kinase (JNK) pathway. Conclusions—: SDF-1α promoted neurogenesis and angiogenesis during the postacute phase of ischemia without eliciting an inflammatory response. AAV-SDF-1α expression represents a promising avenue for ischemic stroke therapy with a wider treatment window.Keywords
This publication has 34 references indexed in Scilit:
- Adult SVZ Lineage Cells Home to and Leave the Vascular Niche via Differential Responses to SDF1/CXCR4 SignalingCell Stem Cell, 2010
- Endothelial progenitor cell transplantation improves long‐term stroke outcome in miceAnnals of Neurology, 2010
- Effects of CXCR4 Gene Transfer on Cardiac Function After Ischemia-Reperfusion InjuryThe American Journal of Pathology, 2010
- The CXCL12 (SDF-1)/CXCR4 Axis Is Essential for the Development of Renal VasculatureJournal of the American Society of Nephrology, 2009
- Shp2 acts downstream of SDF-1α/CXCR4 in guiding granule cell migration during cerebellar developmentDevelopmental Biology, 2009
- Neural Stem/Progenitor Cells Promote Endothelial Cell Morphogenesis and Protect Endothelial Cells against Ischemia via HIF-1α-Regulated VEGF SignalingJournal of Cerebral Blood Flow & Metabolism, 2008
- Regional Distribution of Cortical Interneurons and Development of Inhibitory Tone Are Regulated by Cxcl12/Cxcr4 SignalingThe Journal of Neuroscience, 2008
- The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesisTrends in Immunology, 2007
- High-level expression of functional chemokine receptor CXCR4 on human neural precursor cellsDevelopmental Brain Research, 2004
- Role of the α‐chemokine stromal cell‐derived factor (SDF‐1) in the developing and mature central nervous systemGlia, 2003